Actively Recruiting
Molecular Analysis of the Knee Joint Microbiome During Primary or Revision ACL Reconstruction Surgery Using Next-Generation Sequencing
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2026-08-20
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the knee joint microbiome in patients undergoing anterior cruciate ligament ACL reconstruction or revision surgery. The study aims to understand silent infections and disruptions in the knees microbial environment that may cause failure after ACL surgery. Traditional infection detection methods often miss these silent infections, so advanced molecular techniques like next-generation sequencing NGS are being evaluated for their improved sensitivity. Participants in this trial will have tissue samples from their ACL surgery analyzed using NGS. The study focuses on patients receiving a graft treated with antibiotics, specifically vancomycin, during ACL reconstruction. This diagnostic approach seeks to better characterize the microbial profile of the knee joint during surgery. During the study, participants will undergo tissue sampling on the day of surgery for microbiome analysis. Researchers will describe the knee microbiome based on this sample. The study does not involve blinding or randomization and tracks the microbial environment at one time point. Participants will be monitored through surgery to understand infection and microbiome status, with study completion expected in 2027.
CONDITIONS
Brief Title
Microbiological Molecular Profile of the Knee Joint During Primary Reconstruction or Revision Surgery of the ACL
Research Team
B
Bertrand SONNERY-COTTET, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here